The estimated Net Worth of Bastiano Sanna is at least $25.7 Million dollars as of 5 May 2023. Bastiano Sanna owns over 3,272 units of Vertex Pharmaceuticals stock worth over $15,209,720 and over the last 4 years Bastiano sold VRTX stock worth over $10,535,018.
Bastiano has made over 21 trades of the Vertex Pharmaceuticals stock since 2021, according to the Form 4 filled with the SEC. Most recently Bastiano sold 3,272 units of VRTX stock worth $1,145,200 on 5 May 2023.
The largest trade Bastiano's ever made was selling 7,567 units of Vertex Pharmaceuticals stock on 12 April 2023 worth over $2,472,139. On average, Bastiano trades about 1,009 units every 23 days since 2021. As of 5 May 2023 Bastiano still owns at least 32,038 units of Vertex Pharmaceuticals stock.
You can see the complete history of Bastiano Sanna stock trades at the bottom of the page.
Bastiano's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: